Sustained heavy drinking over 25 years is associated with increased N-terminal-pro-B-type natriuretic peptides in early old age: Population-based cohort study.


Journal

Drug and alcohol dependence
ISSN: 1879-0046
Titre abrégé: Drug Alcohol Depend
Pays: Ireland
ID NLM: 7513587

Informations de publication

Date de publication:
01 07 2020
Historique:
received: 26 02 2020
revised: 01 04 2020
accepted: 21 04 2020
pubmed: 26 5 2020
medline: 3 3 2021
entrez: 26 5 2020
Statut: ppublish

Résumé

Heavy alcohol consumption is associated with an increased risk of heart failure. We sought to investigate whether levels of NT-proBNP differ by alcohol consumption profiles, both current drinking as well as cumulative exposure to drinking over several decades in a general population sample. Data on 2054 participants (49% male) were taken from the UK Medical Research Council National Survey for Health and Development, a longitudinal cohort study based on a nationally representative sample of births in 1946. Categories of long-term alcohol consumption were created based on consumption over 25 years of observations and compared with levels of NT-proBNP measured at mean age 63. We found that those who drank heavily (both currently and long-term) had higher levels of NT-proBNP than moderate drinkers, after adjusting for major confounders (age, sex, socio-economic position and smoking). As NT-proBNP has attracted attention as a biomarker for heart failure, this suggests a critical pathway through which heavy drinking may increase risk of this cardiovascular disease. When we looked at heavy drinkers who varied their intake over the decades, it was only the recently heavy group that had higher levels of NT-proBNP. Further work is needed to demonstrate whether effects are reversible upon cessation of heavy drinking, but this finding highlights the need to have repeated data to unpack dynamics over time. Our findings suggest heavy drinkers could be screened for NT-proBNP levels in order to identify those at high risk earlier in the clinical stages of heart failure and targeted for risk reduction strategies.

Identifiants

pubmed: 32450480
pii: S0376-8716(20)30213-1
doi: 10.1016/j.drugalcdep.2020.108048
pmc: PMC7301434
pii:
doi:

Substances chimiques

Biomarkers 0
Peptide Fragments 0
pro-brain natriuretic peptide (1-76) 0
Natriuretic Peptide, Brain 114471-18-0

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108048

Subventions

Organisme : British Heart Foundation
ID : RG/13/13/30194
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/13/13/30194
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/18/13/33946
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L003120/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M006638/1
Pays : United Kingdom

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None declared

Références

J Intern Med. 2017 Jan;281(1):75-85
pubmed: 27485145
BMC Med. 2018 Aug 22;16(1):124
pubmed: 30131059
Int J Epidemiol. 2011 Feb;40(1):e1-9
pubmed: 21345808
World J Cardiol. 2014 Aug 26;6(8):771-81
pubmed: 25228956
Am J Cardiol. 2016 Feb 1;117(3):376-81
pubmed: 26739393
J Card Fail. 2018 Dec;24(12):813-814
pubmed: 30527332
J Am Heart Assoc. 2018 Jun 27;7(13):
pubmed: 29950487
Eur J Epidemiol. 2013 May;28(5):393-404
pubmed: 23645505
Circulation. 2019 Apr 23;139(17):1988-1999
pubmed: 30667283
Lancet Diabetes Endocrinol. 2016 Oct;4(10):840-9
pubmed: 27599814
BMJ. 2017 Mar 22;356:j909
pubmed: 28331015
Alcohol Alcohol. 2011 May-Jun;46(3):247-52
pubmed: 21508196
BMC Med. 2016 Jul 29;14(1):111
pubmed: 27473049
BMC Med. 2015 Mar 06;13:47
pubmed: 25858476
Nutr J. 2015 Apr 02;14:33
pubmed: 25889723
Nat Rev Cardiol. 2015 Oct;12(10):576-87
pubmed: 26099843

Auteurs

Annie Britton (A)

Department of Epidemiology and Public Health, University College London, London, WC1E 6BT, UK. Electronic address: a.britton@ucl.ac.uk.

Dara O'Neill (D)

Department of Epidemiology and Public Health, University College London, London, WC1E 6BT, UK; CLOSER, UCL Institute of Education, University College London, London, UK.

Diana Kuh (D)

MRC Unit for Lifelong Health and Ageing at University College London, London, UK.

Steven Bell (S)

Department of Epidemiology and Public Health, University College London, London, WC1E 6BT, UK; Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Wort's Causeway, Cambridge, CB1 8RN, UK; Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH